TCT-228 Outcomes After Treatment of Coronary In-Stent Restenosis With Drug-Coated Balloon Versus Drug-Eluting Stent According to the Presence or Absence of Diabetes Mellitus: A Prespecified Analysis of the DAEDALUS Study

Autor:	Robert A. Byrne, Tom Adriaenssens, Duk-Woo Park, Daniele Giacoppo, Leos Pleva, Ralf Degenhardt, Bo Xu, Maria Perez-Vizcayno, Christoph Naber, Seung-Jung Park, Jose Ps. Henriques, Fernando Alfonso, Do-Yoon Kang, Bimmer E. Claessen, Runlin Gao, Adnan Kastrati, Jan Baan
Rok vydání:	2018
Předmět:	medicine.medical_specialty Drug coated balloon business.industry medicine.medical_treatment Stent equipment and supplies medicine.disease Balloon Restenosis Drug-eluting stent Diabetes mellitus Internal medicine medicine Cardiology In stent restenosis Cardiology and Cardiovascular Medicine business After treatment
Zdroj:	Journal of the American College of Cardiology. 72:B95
ISSN:	0735-1097
DOI:	10.1016/j.jacc.2018.08.1352
Popis:	Drug-coated balloon (DCB) and drug-eluting stent (DES) have emerged as the most effective treatments for coronary in-stent restenosis (ISR). The main analysis of the DAEDALUS study showed that DES reduces target lesion revascularization (TLR) at long-term follow-up compared with DCB. The DAEDALUS
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::f81f62145ca6678c43de6ae279d6b676 https://doi.org/10.1016/j.jacc.2018.08.1352 Zobrazit plný text záznamu